Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Evaluation of Subjective Ratings of Appetite and Glucoregulation of a Low Calorie Diet Supplemented With a High Viscosity Polysaccharide (PolyGlycopleX - PGX) [Phase 3]
Phase 3 clinical trial evaluating subjective appetite and postprandial glucoregulation with a low-calorie diet supplemented by PGX. The stud…
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Gastric Sleeve Pilot Study in Morbidly Obese Undergoing Liver Transplantation [Phase 1]
This is an update on a Phase 1 pilot study evaluating gastric sleeve surgery in morbidly obese patients undergoing liver transplantation; th…
-
CLINICAL_TRIALS research · 2015-10-01Clinical Trial Update: A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunteers [Phase 1]
A Phase 1 pharmacokinetic study comparing CKD-395 at 0.5/1000 mg in healthy male volunteers was completed; sponsor is Chong Kun Dang Pharmac…
-
FDA approval · 2015-09-29FDA Approved: TOUJEO — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for TOUJEO (insulin glargine) from Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: A Study of LY2189265 in Japanese Patients With Type 2 Diabetes [Phase 2]
Phase 2 clinical trial results for LY2189265 in Japanese patients with type 2 diabetes have been completed and results posted. The study was…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-09-28FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Metformin hydrochloride from Sun Pharmaceutical Industries, marking an updated approval for …
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial comparing Fasiglifam (TAK-875) with Sitagliptin, each added to Metformin, in adults with Type 2 diabetes; the study was term…
-
FDA approval · 2015-09-25FDA Approved: TRESIBA — Original Application (Novo Nordisk)
FDA approved the original Biologics License Application for Tresiba (insulin degludec) from Novo Nordisk, establishing a long-acting insulin…
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Improving Diabetes Outcomes Through Lifestyle Change (IDOLc)Study [NA]
The IDOLc study investigating lifestyle-change strategies to improve outcomes in adults with type 2 diabetes mellitus and obesity has comple…
-
CLINICAL_TRIALS trial_result · 2015-09-24Clinical Trial Update: Effects of Pomegranate Juice on Oxidative Stress in Patients With type2 Diabetes [Phase 4]
Phase 4 trial evaluating whether pomegranate juice reduces oxidative stress in adults with type 2 diabetes.
-
CLINICAL_TRIALS research · 2015-09-24Clinical Trial Update: Blood Flow Responses to an Oral Glucose Tolerance Test in Type 2 Diabetes [NA]
This clinical trial update notes that a University of Kansas Medical Center study examining blood flow responses during an oral glucose tole…
-
CLINICAL_TRIALS trial_result · 2015-09-24Clinical Trial Update: Soccer and Health: Diet and Exercise on Type 2 Diabetes Mellitus [NA]
This clinical trial update reports the completion of a study by University of Sao Paulo General Hospital examining the effects of diet and e…
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Evaluation of the Bioavailability of Pramlintide [Phase 2]
Phase 2 study evaluating the bioavailability of pramlintide in patients with type 1 or type 2 diabetes has completed. The document reports t…
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Medium-term Health Coaching and Life-long Monitoring in Diabetes Mellitus [NA]
A completed clinical study evaluating medium-term health coaching and lifelong monitoring for adults with Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2015-09-23Clinical Trial Update: Plant-based Ingredient on Post Prandial Glucose in Type II Diabetes [NA]
A completed clinical trial evaluated a plant-based ingredient's effect on postprandial glucose in adults with type 2 diabetes, sponsored by …
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: Vitamin D for the Prevention of Diabetes Type 2 [Phase 2, Phase 3]
A Phase 2/3 trial tested whether Vitamin D supplementation can prevent type 2 diabetes in people with impaired glucose tolerance. The study …
-
CLINICAL_TRIALS trial_result · 2015-09-21Clinical Trial Update: Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks [Phase 2]
Phase 2 clinical trial assessing the efficacy, safety, and tolerability of Met DR in adults with Type 2 Diabetes Mellitus over 12 weeks. The…
-
FDA approval · 2015-09-18FDA Approved: JENTADUETO — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for JENTADUETO (linagliptin/metformin hydrochloride) from Boehringer Ingelheim Pharmaceuticals, …
-
FDA approval · 2015-09-18FDA Approved: PIOGLITAZONE HCL AND METFORMIN HCL — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for a generic Pioglitazone HCl and Metformin HCl combination product…
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: Effect of Vitamin D Supplementation on Glucose Tolerance in Subjects at Risk for Diabetes With Low Vitamin D. [Phase 2]
Phase 2 trial evaluating whether vitamin D supplementation improves glucose tolerance in individuals at risk for diabetes with low vitamin D…
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: Effect of Diacerein in the Metabolic Control of Patients With DM Type 2 and Secondary Failure to Metformin [Phase 2]
A Phase 2 clinical trial is evaluating Diacerein for metabolic control in patients with Type 2 diabetes who have secondary failure to Metfor…
-
FDA approval · 2015-09-16FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)
The FDA approved a supplemental application for AFREZZA (insulin human) from MannKind Corporation.
-
CLINICAL_TRIALS trial_result · 2015-09-16Clinical Trial Update: Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes [Phase 3]
The document reports Phase 3 trial results on the efficacy and safety of a once-weekly exenatide suspension in adults with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2015-09-16Clinical Trial Update: The Effect of Walking Meditation Training on Glycemic Control and Vascular Function in Patients With Type 2 Diabetes [NA]
This completed clinical trial evaluated the effect of walking meditation training on glycemic control and vascular function in patients with…
-
CLINICAL_TRIALS trial_result · 2015-09-15Clinical Trial Update: Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users [Phase 4]
Phase 4 trial evaluating differences in endothelial function between users of sitagliptin and liraglutide in adults with Type 2 diabetes mel…